Published in Dev Cell on October 01, 2004
The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature (2009) 6.99
The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct (2006) 5.21
Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J Cell Biol (2008) 4.66
Membrane scission by the ESCRT-III complex. Nature (2009) 4.66
Exosome function: from tumor immunology to pathogen biology. Traffic (2008) 4.50
Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol (2010) 4.29
Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol (2007) 4.08
Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature (2010) 4.05
The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell (2007) 2.99
The ESCRT complexes. Crit Rev Biochem Mol Biol (2010) 2.23
Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell (2007) 2.21
bicoid RNA localization requires specific binding of an endosomal sorting complex. Nature (2007) 2.11
Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol (2006) 2.06
Membrane fission reactions of the mammalian ESCRT pathway. Annu Rev Biochem (2013) 1.91
vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development (2006) 1.79
Structural basis for autoinhibition of ESCRT-III CHMP3. J Mol Biol (2008) 1.78
Coarse-grained models for simulations of multiprotein complexes: application to ubiquitin binding. J Mol Biol (2007) 1.74
ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J (2010) 1.66
Golgi localization of glycosyltransferases requires a Vps74p oligomer. Dev Cell (2008) 1.62
Structural insight into the ESCRT-I/-II link and its role in MVB trafficking. EMBO J (2007) 1.60
Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perspect Biol (2013) 1.58
Structural and functional organization of the ESCRT-I trafficking complex. Cell (2006) 1.51
Structural role of Sfi1p-centrin filaments in budding yeast spindle pole body duplication. J Cell Biol (2006) 1.51
No strings attached: the ESCRT machinery in viral budding and cytokinesis. J Cell Sci (2009) 1.50
Structure and function of the ESCRT-II-III interface in multivesicular body biogenesis. Dev Cell (2009) 1.50
Human CHMP6, a myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component EAP20 and regulates endosomal cargo sorting. Biochem J (2005) 1.48
Exploring the ESCRTing machinery in eukaryotes. Trends Plant Sci (2006) 1.47
Integrated structural model and membrane targeting mechanism of the human ESCRT-II complex. Dev Cell (2008) 1.40
New component of ESCRT-I regulates endosomal sorting complex assembly. J Cell Biol (2006) 1.35
MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between. Curr Opin Cell Biol (2011) 1.33
Association of the endosomal sorting complex ESCRT-II with the Vps20 subunit of ESCRT-III generates a curvature-sensitive complex capable of nucleating ESCRT-III filaments. J Biol Chem (2011) 1.18
Bro1 binding to Snf7 regulates ESCRT-III membrane scission activity in yeast. J Cell Biol (2011) 1.17
The ESCRT machinery: from the plasma membrane to endosomes and back again. Crit Rev Biochem Mol Biol (2014) 1.12
PalC, one of two Bro1 domain proteins in the fungal pH signalling pathway, localizes to cortical structures and binds Vps32. Traffic (2007) 1.11
CHMP7, a novel ESCRT-III-related protein, associates with CHMP4b and functions in the endosomal sorting pathway. Biochem J (2006) 1.09
Solution structure of the ESCRT-I and -II supercomplex: implications for membrane budding and scission. Structure (2012) 1.06
Structural analysis and modeling reveals new mechanisms governing ESCRT-III spiral filament assembly. J Cell Biol (2014) 1.03
Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell division. Mol Cell (2011) 1.03
Common and distinct genetic properties of ESCRT-II components in Drosophila. PLoS One (2009) 1.00
Membrane protein targeting to the MVB/lysosome. Chem Rev (2009) 0.95
Reconstructing the ubiquitin network: cross-talk with other systems and identification of novel functions. Genome Biol (2009) 0.92
Endosomal sorting complex required for transport (ESCRT) complexes induce phase-separated microdomains in supported lipid bilayers. J Biol Chem (2012) 0.91
Reverse-topology membrane scission by the ESCRT proteins. Nat Rev Mol Cell Biol (2016) 0.90
Chromosomal replication initiation machinery of low-G+C-content Firmicutes. J Bacteriol (2012) 0.90
Assembly and disassembly of the ESCRT-III membrane scission complex. FEBS Lett (2011) 0.89
Vesicle formation within endosomes: An ESCRT marks the spot. Commun Integr Biol (2012) 0.88
Structure of the N-terminal oligomerization domain of DnaD reveals a unique tetramerization motif and provides insights into scaffold formation. J Mol Biol (2007) 0.88
Variance heterogeneity in Saccharomyces cerevisiae expression data: trans-regulation and epistasis. PLoS One (2013) 0.87
ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission. J Cell Biol (2016) 0.86
Crystal structure of subunit VPS25 of the endosomal trafficking complex ESCRT-II. BMC Struct Biol (2004) 0.86
Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family. J Biol Chem (2015) 0.83
Where do they come from and where do they go: candidates for regulating extracellular vesicle formation in fungi. Int J Mol Sci (2013) 0.83
Dimer formation and conformational flexibility ensure cytoplasmic stability and nuclear accumulation of Elk-1. Nucleic Acids Res (2011) 0.82
The VPS-20 subunit of the endosomal sorting complex ESCRT-III exhibits an open conformation in the absence of upstream activation. Biochem J (2015) 0.81
ESCRT regulates surface expression of the Kir2.1 potassium channel. Mol Biol Cell (2013) 0.80
Constitutively active ESCRT-II suppresses the MVB-sorting phenotype of ESCRT-0 and ESCRT-I mutants. Mol Biol Cell (2014) 0.79
Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production. Retrovirology (2015) 0.79
The MORPHEUS II protein crystallization screen. Acta Crystallogr F Struct Biol Commun (2015) 0.78
Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy. Oncotarget (2015) 0.77
Genetic structure and evolution of the Vps25 family, a yeast ESCRT-II component. BMC Evol Biol (2006) 0.77
Membrane Binding by CHMP7 Coordinates ESCRT-III-Dependent Nuclear Envelope Reformation. Curr Biol (2016) 0.76
ELL targets c-Myc for proteasomal degradation and suppresses tumour growth. Nat Commun (2016) 0.76
The structure of an endosomal protein sorter. Dev Cell (2004) 0.75
VPS36-dependent Multivesicular Bodies are Critical for Plasmamembrane Protein Turnover and Vacuolar Biogenesis. Plant Physiol (2016) 0.75
Dual function of the pUL7-pUL51 tegument protein complex in HSV-1 infection. J Virol (2016) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell (2006) 10.06
Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science (2007) 5.19
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol (2008) 3.84
Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4. Nature (2007) 3.47
Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science (2013) 3.33
Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science (2010) 3.20
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol (2010) 3.15
A role for the ESCRT system in cell division in archaea. Science (2008) 2.94
[Does body mass index influence mortality in patients with heart failure?]. Rev Esp Cardiol (2007) 2.73
Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol Cell (2011) 2.50
ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes. Cell (2006) 2.38
Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J (2002) 2.09
Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA). Proc Natl Acad Sci U S A (2012) 2.04
[Prevalence of anemia and its correlation with clinical parameters in patients from a multidisciplinary heart failure unit]. Med Clin (Barc) (2004) 2.02
Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24. Structure (2008) 1.95
Robotic nanolitre protein crystallisation at the MRC Laboratory of Molecular Biology. Prog Biophys Mol Biol (2004) 1.86
PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol Cell (2003) 1.78
[Noninvasive remote telemonitoring for ambulatory patients with heart failure: effect on number of hospitalizations, days in hospital, and quality of life. CARME (CAtalan Remote Management Evaluation) study]. Rev Esp Cardiol (2011) 1.72
Structural basis for Arl1-dependent targeting of homodimeric GRIP domains to the Golgi apparatus. Mol Cell (2003) 1.70
Structural basis for activation and inhibition of class I phosphoinositide 3-kinases. Sci Signal (2011) 1.68
Structural insight into the ESCRT-I/-II link and its role in MVB trafficking. EMBO J (2007) 1.60
Structural insights into endosomal sorting complex required for transport (ESCRT-I) recognition of ubiquitinated proteins. J Biol Chem (2004) 1.57
Structural role of Sfi1p-centrin filaments in budding yeast spindle pole body duplication. J Cell Biol (2006) 1.51
Dynamics of the phosphoinositide 3-kinase p110δ interaction with p85α and membranes reveals aspects of regulation distinct from p110α. Structure (2011) 1.48
Orbicularis oris muscle defects as an expanded phenotypic feature in nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A (2007) 1.48
Lack of medication dose uniformity in commonly split tablets. J Am Pharm Assoc (Wash) (2002) 1.46
[Prognostic significance of hemoglobin levels in patients with heart failure]. Rev Esp Cardiol (2005) 1.45
Balancing efficacy and safety in the use of oral sedation in dental outpatients. J Am Dent Assoc (2006) 1.42
[Prognostic significance of diabetes in a heart failure population: one year mortality and heart failure related hospital admission]. Med Clin (Barc) (2005) 1.42
Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase. Mol Cell (2004) 1.39
G protein-coupled receptor-mediated activation of p110β by Gβγ is required for cellular transformation and invasiveness. Sci Signal (2012) 1.38
[Clinical, echocardiographic and prognostic evaluation of atrial fibrillation in patients with heart failure]. Med Clin (Barc) (2007) 1.38
Application of USP-NF Standard to Pharmacy Compounding. Int J Pharm Compd (2013) 1.27
Structural and membrane binding analysis of the Phox homology domain of Bem1p: basis of phosphatidylinositol 4-phosphate specificity. J Biol Chem (2007) 1.22
Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol (2008) 1.17
The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance. Pharm Res (2008) 1.13
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the Americas. AAPS J (2012) 1.12
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS. EMBO J (2007) 1.11
Crystal structures of Paenibacillus polymyxa beta-glucosidase B complexes reveal the molecular basis of substrate specificity and give new insights into the catalytic machinery of family I glycosidases. J Mol Biol (2007) 1.11
The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure (2012) 1.09
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail (2012) 1.08
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs). Proc Natl Acad Sci U S A (2013) 1.06
Structural and kinetic analysis of Schwanniomyces occidentalis invertase reveals a new oligomerization pattern and the role of its supplementary domain in substrate binding. J Biol Chem (2010) 1.06
Structural and membrane binding analysis of the Phox homology domain of phosphoinositide 3-kinase-C2alpha. J Biol Chem (2006) 1.05
Dynamic steps in receptor tyrosine kinase mediated activation of class IA phosphoinositide 3-kinases (PI3K) captured by H/D exchange (HDX-MS). Adv Biol Regul (2012) 1.05
Molecular and structural basis of ESCRT-III recruitment to membranes during archaeal cell division. Mol Cell (2011) 1.03
The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase. Adv Enzyme Regul (2004) 1.02
Structural studies of phosphoinositide 3-kinase-dependent traffic to multivesicular bodies. Biochem Soc Symp (2007) 0.99
Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature (2013) 0.98
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. J Transl Med (2012) 0.97
Patients' self-care improvement with nurse education intervention in Spain assessed by the European Heart Failure Self-Care Behaviour Scale. Eur J Cardiovasc Nurs (2007) 0.96
The USP Performance Verification Test, Part II: collaborative study of USP's Lot P Prednisone Tablets. Pharm Res (2008) 0.94
The barrier to enantiomerization of N-Boc-2-lithiopyrrolidine: the effect of chiral and achiral diamines. Chem Commun (Camb) (2008) 0.93
Using Medicare administrative data to conduct postmarketing surveillance of follow-on biologics: issues and opportunities. Food Drug Law J (2008) 0.93
The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol (2010) 0.92
Structural insights into the specificity of Xyn10B from Paenibacillus barcinonensis and its improved stability by forced protein evolution. J Biol Chem (2009) 0.91
A segment of cold shock protein directs the folding of a combinatorial protein. Proc Natl Acad Sci U S A (2005) 0.91
Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol (2012) 0.91
Selected medication-error data from USP's MEDMARX program for 2002. Am J Health Syst Pharm (2004) 0.89
Improving the safety of neuromuscular blocking agents: a statement from the USP Safe Medication Use Expert Committee. Am J Health Syst Pharm (2006) 0.89
Evaluation of a telemedicine system for heart failure patients: feasibility, acceptance rate, satisfaction and changes in patient behavior: results from the CARME (CAtalan Remote Management Evaluation) study. Eur J Cardiovasc Nurs (2012) 0.88
Three-dimensional structure of Saccharomyces invertase: role of a non-catalytic domain in oligomerization and substrate specificity. J Biol Chem (2013) 0.88
A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers. J Allergy Clin Immunol (2002) 0.87
Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis. J Rheumatol (2012) 0.87
Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value. Eur J Heart Fail (2012) 0.86
Post-epizootic chronic dolphin morbillivirus infection in Mediterranean striped dolphins Stenella coeruleoalba. Dis Aquat Organ (2011) 0.86
The structural basis of novel endosome anchoring activity of KIF16B kinesin. EMBO J (2007) 0.86
Basal cell carcinoma in childhood after radiation therapy: case report and review. Ann Plast Surg (2004) 0.86
Conformational changes in inositol 1,3,4,5,6-pentakisphosphate 2-kinase upon substrate binding: role of N-terminal lobe and enantiomeric substrate preference. J Biol Chem (2012) 0.85
Metal impurities in food and drugs. Pharm Res (2010) 0.85
PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control. PLoS Biol (2013) 0.85
Socio-demographic, clinical and treatment characteristics of relapsing schizophrenic patients. Nord J Psychiatry (2012) 0.85
Progressively reducing regulatory burden. AAPS J (2014) 0.85
Exploring changes in dental workforce, dental care utilisation and dental caries levels in Europe, 1990-2004. Int Dent J (2009) 0.85
Evolution and assembly of ESCRTs. Biochem Soc Trans (2009) 0.85
ESCRT-III binding protein MITD1 is involved in cytokinesis and has an unanticipated PLD fold that binds membranes. Proc Natl Acad Sci U S A (2012) 0.84
Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. J Am Acad Dermatol (2005) 0.84
[Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain]. Rev Esp Cardiol (2004) 0.84
Weight-loss study in African-American Women: lessons learned from project take HEED and future, technologically enhanced directions. Perm J (2013) 0.84
FDA's dietary supplement CGMPs: standards without standardization. Food Drug Law J (2008) 0.84
Serum myostatin levels in chronic heart failure. Rev Esp Cardiol (2010) 0.84